Abstract |
LY294002 and wortmannin are chemical compounds that act as potent inhibitors of phosphoinositide 3-kinases (PI3Ks). Both of them are generally used to inhibit cell proliferation as cancer treatment by inhibiting the PI3K/ protein kinase B (AKT) signaling pathway. In this study, LY294002 (but not wortmannin) showed an abnormal ability to enhance AKT phosphorylation (at Ser472) specifically in gemcitabine (GEM)-resistant pancreatic cancer (PC) cell lines PK59 and KLM1-R. LY294002 was shown to activate AKT and accumulate phospho-AKT at the intracellular membrane in PK59, which was abolished by treatment with AKTi-1/2 or wortmannin. Inhibiting AKT phosphorylation by treatment with AKTi-1/2 or wortmannin further enhanced LY294002-induced cell death in PK59 and KLM1-R cells. In addition, treatment with wortmannin alone failed to inhibit cell proliferation in both PK59 and KLM1-R cells. Thus, our results reveal that LY294002 displays the opposite effect on PI3K-dependent AKT phosphorylation, which maintains cell survival from the cytotoxicity introduced by LY294002 itself in GEM-resistant pancreatic cancer cells. We suggest that targeting the PI3K/AKT signaling pathway with inhibitors may be counterproductive for patients with PC who have acquired GEM-resistance.
|
Authors | Yufeng Wang, Yasuhiro Kuramitsu, Byron Baron, Takao Kitagawa, Kazuhiro Tokuda, Junko Akada, Shin-Ichiro Maehara, Yoshihiko Maehara, Kazuyuki Nakamura |
Journal | International journal of oncology
(Int J Oncol)
Vol. 50
Issue 2
Pg. 606-612
(Feb 2017)
ISSN: 1791-2423 [Electronic] Greece |
PMID | 28000865
(Publication Type: Journal Article)
|
Chemical References |
- Androstadienes
- Chromones
- Morpholines
- Deoxycytidine
- 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
- Proto-Oncogene Proteins c-akt
- Wortmannin
- Gemcitabine
|
Topics |
- Androstadienes
(pharmacology)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Chromones
(pharmacology)
- Deoxycytidine
(analogs & derivatives, pharmacology)
- Drug Resistance, Neoplasm
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Morpholines
(pharmacology)
- Pancreatic Neoplasms
(drug therapy, metabolism)
- Phosphorylation
(drug effects)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Signal Transduction
(drug effects)
- Wortmannin
- Gemcitabine
|